Interim report
Page 1
Note: This document has been translated from the Japanese original for reference purposes only. In the event of any discrepan cy between this translated document and the Japanese original, the original shall prevail. November 6, 2025 Consolidated Financial Results f or the Six Months Ended September 30, 2025 (Under Japanese GAAP) Company name: Nissui Corporation Listing: Tokyo Stock Exchange Securities code: 1332 URL: https://www.nissui.co.jp Representative: Teru Tanaka Representative Director, President & CEO Inquiries: Yoichiro Hiroi Executive Officer, General Manager of Corporate Strategic Planning & IR Department Telephone: +81-3-6206-7037 Scheduled date to file semi-annual securities report: November 13, 2025 Scheduled date to commence dividend payments: December 8, 2025 Preparation of supplementary material on financial results: Yes Holding of financial results briefing: Yes (Yen amounts are rounded down to millions, unless otherwise noted.) 1. Consolidated financial results for the six months ended September 30, 2025 (from April 1, 2025 to September 30, 2025) (1) Consolidated operating results (cumulative) (Percentages indicate year-on-year changes.) Net sales Operating profit Ordinary profit Profit attributable to owners of parent Six months ended Millions of yen % Millions of yen % Millions of yen % Millions of yen % September 30, 2025 452,943 2.8 19,791 14.6 21,213 11.2 14,296 13.7 September 30, 2024 440,682 8.2 17,276 6.1 19,085 12.1 12,576 7.6 Note: Comprehensive income For the six months ended September 30, 2025: ¥ 9,374 million [ (67.5) %] For the six months ended September 30, 2024: ¥ 28,821 million [ 15.9 %] Basic earnings per share Diluted earnings per share Six months ended Yen Yen September 30, 2025 46.56 - September 30, 2024 40.46 - (Note) In 3Q FY2025/3, provisional accounting treatment for a business combination at an equity-method affiliate was finalized; figures for the interim consolidated period FY2025/3 were restated accordingly. (2) Consolidated financial position T otal assets Net assets Equity-to-asset ratio As of Millions of yen Millions of yen % September 30, 2025 657,016 283,716 41.7 March 31, 2025 634,878 285,939 43.6 Reference: Equity As of September 30, 2025: ¥ 274,280 million As of March 31, 2025: ¥ 277,039 million 1
Page 2
2 . Cash dividends A nnual dividends per share F irst quarter-end Second quarter-end Third quarter-end Fiscal year-end Total Yen Yen Yen Yen Yen Fiscal year ended - 12.00 - 16.00 28.00 March 31, 2025 Fiscal year ending - 14.00 March 31, 2026 Fiscal year ending March 31, 2026 (Forecast) - 14. 00 28.00 Note: Revisions to the forecast of cash dividends most recently announced: None 3. C onsolidated financial result forecasts for the fiscal year ending March 31, 2026 (from April 1, 2025 to March 31, 2026) (Percentages indicate year-on-year changes.) Net sales Operating profit Ordinary profit Profit attributable to owners of parent Basic earnings per share Millions of yen % Millions of yen % Millions of yen % Millions of yen % Yen Full year 900,000 1.6 34,500 8.6 35,500 0.6 25,000 (1.5) 82.52 Note: Revisions to the financial result forecast most recently announced: None * N otes (1) Significant changes in the scope of consolidation during the period: Yes Newly included: - companies( ) Excluded: 1 companies( Seinan Suisan Co., Ltd. ) (2) Adoption of accounting treatment specific to the preparation of semi-annual consolidated financial statements: None (3) Changes in accounting policies, changes in accounting estimates, and restatement (i) Changes in accounting policies due to revisions to accounting standards and other regulations: None (ii) Changes in accounting policies due to other reasons: None (iii) Changes in accounting estimates: None (iv) Restatement: None (4) Number of issued shares (common shares) (i) Total number of issued shares at the end of the period (including treasury shares) As of September 30, 2025 312,430,277 shares As of March 31, 2025 312,430,277 shares (ii) Number of treasury shares at the end of the period As of September 30, 2025 9,157,246 shares As of March 31, 2025 1,607,331 shares (iii) Average number of shares outstanding during the period (cumulative from the beginning of the fiscal year) Six months ended September 30, 2025 307,034,032 shares Six months ended September 30, 2024 310,828,242 shares (Note) Nissui has introduced the “Board Benefit Trust (BBT)” as its performance-l inked and share-b ased compensation plan since FY2018 and, from the fir st quarter of the curren t consolidated period , has changed to the “Bo ard Benefit Trust-R estricted Stock(BBT-RS).” In addition, its o wn shares remaining in the Trust is includ ed as treasury shares. The number of treasury stocks at the end of the term was 307,526, and the average number of the term was 543, 906. * Semi-annual financial results reports are exempt from review conducted by certified public accountants or an audit firm. 2
Page 3
* Proper use of earnings forecasts, and other special matters The performance forecasts in this report are based on information available at present and certain premises thought to be reasonable. Accordingly, the results may change substantially due to various factors. For conditions from which the premises for the forecasts were derived and the other noteworthy items relating to the use of the forecasts, please refer to “ (3) Explanation of Consolidated Financial Forecasts on page 8 of the “1. Qualititaive information for the interiim of the fiscal year ending March 31, 2026.” 3
Page 4
1. Qualitative information for the interim of the fiscal year ending March 31, 2026 In the third quarter of the previous fiscal year, the Company finalized the provisional accounting treatment for a business combination involving an equity-method affiliate. Accordingly, the figures for the interim consolidated period of the previous fiscal year have been restated to reflect that finalization, and these restated amounts are used for comparison and analysis herein. For further details, please refer to “2. Quarterly Consolidated Financial Statements and Primary Notes (4) Notice concerning the consolidated financial statements (Additional Information)”on page 15. (1) Expla nation of consolidated financial results During the interim consolidated period, the Japanese economy continued its moderate recovery, driven by increased inbound demand and improvements in employment and income conditions. However, uncertainty persists due to downside economic risks stemming from geopolitical risks and the U.S. tariff policies, as well as consumers growing propensity to cut spending in response to rising prices. Regar ding the global economy (from January to June), a highly uncertain economic environment persisted, as supply and demand fluctuated markedly due to a last -minute surge in demand ahead of planned U.S. tariff hikes and the subsequent reversal. Under the Medium Term Management Plan “GOOD FOODS Recipe 2, launched in April 2025, our company and its group are reinforcing their business portfolio by pursuing (1) growth in international business, (2) advancement of the aquaculture business, and (3) turnaround of unprofitable operations. During t he interim consolidated period, a delayed recovery in the domestic seafood trading business and higher raw-material costs in the processed foods business weighed on results. Even so, profits improved in the fishery and aquaculture businesses and the North American seafood processing business—both of which had struggled in the previous fiscal year— while the domestic chilled foods business remained firm. In the c urrent situation, our consolidated business performance for the first quarter cumulative period is as follows: net sales were 452,943 million yen, up 12,260 million yen year-on-year; operating profit was 19,791 million yen, up 2,515 million yen year-on-year; ordinary profit was 21,213 million yen, up 2,128 million yen year-on-year; and profit attributable to owners of parent was 14,296 million yen, up 1,720 million yen year-on-year. (Unit: million yen) Net Sales Operating Profit Ordinary Profit Profit attributable to owners of parent 2Q of FY2025 452,943 19,791 21,213 14,296 2Q of FY2024 440,682 17,276 19,085 12,576 Difference 12,260 2,515 2,128 1,720 Percentage difference (%) 102.8% 114.6% 111.2% 113.7% 4
Page 5
The summary by segment is as follows. (Unit: million yen) Net Sales Increase /Decrease (Y-on-Y) Y-on-Y Operating Profit ＆ loss Increase /Decrease (Y-on-Y) Y-on-Y Marine Products 178,806 3,215 101.8% 6,078 2,566 173.0% Food Products 251,790 11,931 105.0% 16,830 506 103.1% Fine Chemicals 7,109 (189) 97.4% 174 69 165.4% General Distribution 8,356 102 101.2% 1,238 (86) 93.5% Other (Note) 6,879 (2,800) 71.1% 346 (279) 55.3% Common Costs － － －% (4,877) (261) 105.7% Total 452,943 12,260 102.8% 19,791 2,515 114.6% ( Note) “Other” refers to Engineering (planning, design, construction of plants and equipment) business, Ship Operation Business, etc. (1 ) Ma rine Products Business The Marine Products segment is engaged in the fishery, aquaculture, and seafood processing and trading businesses. <Overview of the interim of the consolidated fiscal > We recorded 178,806 million yen (up 3,215 million yen year-on-year) in sales and operating profit of 6,078 million yen (up 2,566 million yen year-on-year) in the Marine Products Business. F ishery Business: Sales decreased but profit increased year on year. [Japan] S olid Japanese amberjack and tuna catches drove higher profits. A quaculture Business: Sales decreased but profit increased year on year. [Japan] Although the selling prices of Japanese amberjack and coho salmon increased, competition in tuna intensified due to greater supplies of wild-caught and imported tuna. As a result, overall sales declined, but profits rose. [South America] Selling prices rose on a market recovery, and aquaculture performance such as survival rates improved. However, partly due to foreign exchange effects, sales decreased, and profits increase d. P rocessing and Trading Business: Sales increased but profit decreased year on year. [Japan] Although sales of Japanese amberjack and other products remained firm, falling fish oil prices, higher raw-materia l c osts for salmon and trout, and a decrease in shrimp sales volume resulted in lower sales and profits. [North America] Sales of Alaska pollock fillets and surimi were steady in both volume and price, while trading saw solid sales of cod, salmon and trout, and crab delivering higher sales and profits . [ Europe] Sales were strong in Italy, the Benelux, and other markets, led by major products such as shrimp and salmon and trout; however, partly due to foreign exchange effects, sales increased while profits decreased. ( 2) Food Products Business The Food Products segment is engaged in the food processing and chilled foods businesses. 5
Page 6
< Overview of the interim of the consolidated fiscal year> We recorded 251,790 million yen (up 11,931 million yen year-on-year) in sales and an operating profit of 16,830 million yen (up 506 million yen year-on-year) in the Food Products Business. P rocessed Foods Business: Sales increased, but profit decreased year on year. [Japan] For household use sales of fish sausages and fish cakes continued to perform well, and food service frozen products for restaurants and supermarket delicatessen counters remained solid. However, higher rice and surimi raw material costs could not be fully offset by price revisions, resulting in lower profits. [North America] For household use sales remained firm and expanded market share, while the food service segment struggled amid weaker dining out demand and higher shrimp raw material costs; overall, sales declined but profits increased. [Europe] Strong sales in France, the UK and Spain, together with ample inventories of white fish raw materials held ahead of the price increases, generated higher profits. C hilled Foods Business: Both sales and profits increased year on year. Effective sales promotions at convenience stores drove continued strong sales of bento, prepared noodles, and delicatessen items, resulting in higher sales and profits . ( 3) F ine Chemicals Business The Fine Chemicals segment is engaged in manufacturing and selling pharmaceutical raw materials, functional raw materials (Note 1), and functional foods (Note 2). < Overview of the interim of the consolidated fiscal year > We recorded 7,109 million yen (down 189 million yen year-on-year) in sales and an operating profit of 174 million yen (up 69 million yen year-on-year) in the Fine Chemicals Business. D omestic sales of functional raw materials for supplements remained firm, —together with pharmaceutical raw materials sales mainly scheduled for the second half—resulted in lower sales and profits. ( 4) G eneral Distribution Business The General Distribution segment is engaged in cold storage, transportation, and customs clearance businesses. < Overview of the interim of the consolidated fiscal year > We recorded 8,356 million yen (up 102 million yen year-on-year) in sales and an operating profit of 1,238 million yen (down 86 million yen year-on-year) in the General Distribution Business. Although the volume handled remained firm and the effects of price revisions were evident, increased personnel expenses associated with additional staffing amid the logistics “2024 problem,” together with higher fuel costs, resulted in higher sales but lower profits. 6
Page 7
(N ote 1) EPA, DHA, and others mainly used as ingredients in health supplements and infant formula (Note 2) Supplements such as “Sesame soy milk” functional food and “i-mark S,” food for specified health uses (FOSHU), mainly for online business (2) Exp lanation of the consolidated financial position (1) State of assets, liabilities, and net assets (Unit: million yen) FY2024 2Q of FY2025 Increase/Decrease Current Assets 332,568 344,412 11,844 (Inventories) 195,008 198,336 3,327 Non-current Assets 302,309 312,603 10,293 Total Assets 634,878 657,016 22,137 Current Liabilities 226,179 232,895 6,715 Non-current Liabilities 122,758 140,403 17,644 Total Liabilities 348,938 373,299 24,360 Total Net Assets 285,939 283,716 (2,223) Assets Total assets increased by 22,137 million yen to 657,016 million yen compared to the end of the previous consolidated fiscal year (up 3.5 %). Current assets increased by 11,844 million yen to 344,412 million yen (up 3.6%). This is mainly because cash and deposits increased by 4,9 95 million yen, the inventory increased by 3,327 million ye n, in addition to notes and accounts receivable increased by 2,843 million yen due to increased sales. Non-current assets increased by 10,293 million yen to 312,603 million yen (up 3.4%), mainly due to increased property, plant, and equipment costs by 7,433 million yen of capital investment. Liabilities Total liabilities increased by 24,3 60 million yen to 37 3,299 milli on ye n compared t o the e nd of the previous consolidated fiscal year (up 7.0%). Current liabilities increased by 6,715 million yen to 232,895 million yen (up 3.0%), mainly because of increased short-term borrowings by 7,735 million yen due to increased demand for working capital. Non-current liabilities increased by 17,644 million yen to 140,403 million yen (up 14.4%). The main reason was an increase in long-term borrowings by 17,032 million yen. Net Assets Total ne t assets decreased by 2,2 23 million yen to 28 3,716 million yen compare d t o the end of the previous consolidated fiscal year (down 0.8%). This is mainly due to posting a profit attributable to owners of the parent of 14,296 million yen, payi ng surplus dividends by 4,985 million yen, and decreasing foreign currency translation adjustment by 6,727 million yen due to the weak yen. Also, there was an increase in treasury stock by 5,861 million yen mainly due to the tender offer. 7
Page 8
(2) State of cash flows (Unit: million yen) 2Q of FY2024 2Q of FY2025 Increase /Decrease Net cash provided by operating activities 13,406 16,543 3,137 Net cash used in investing activities (16,308) (25,633) (9,324) Net cash provided by financing activities 2,359 14,446 12,086 Cash and cas h equivalent at the end of period 20,034 23,843 3,809 Net cash flows provided by operating activities were 16,543 million yen (increased by 3,137 million yen compared to the same period of the previous year). This was due to the total interim net profit and depreciation expense before adjustment for taxes and other expenses were 33,742 million yen. Meanwhile, the decrease in funds due to an increase in inventory was 11,292 million yen, and the amount paid for corporate tax was 4,218 million yen. Net cash flows used in investment activities were 25,633 million yen (increased by 9,324million yen compared to the same period of the previous year). This was mainly due to the expenditure of 24,356 million yen related to acquiring property, plant, and equipment associated with investments in production facilities in Japan and overseas. Net cash flows provided by financing activities were 14,446 million yen (increased by 12,086 million compared to the same period of the previous year). This was due to an increase in short-term borrowings of 26,862 million yen, while dividends paid were 4,978 million yen and expenditure from treasury stock acquisitions was 6,073 million yen. (3) Explanation of Consolidated Financial Forecasts Regarding the full-year earnings forecast and dividend forecast, we do not change the forecast announced on May 14, 2025. 8
Page 9
2.Semi-annual Consolidated Financial Statements and Primary Notes (1) S emi-annual Consolidated Balance Sheet (Millions of yen) As of March 31, 2025 As of September 30, 2025 Assets Current assets Cash and deposits 14,707 19,703 Notes and accounts receivable - trade 107,400 110,243 Merchandise and finished goods 102,564 103,100 Work in process 33,172 36,611 Raw materials and supplies 59,271 58,624 Other 16,067 16,674 Allowance for doubtful accounts (616) (545) Total current assets 332,568 344,412 Non-current assets Property, plant and equipment Buildings and structures, net 68,204 66,649 Other, net 112,734 121,722 Total property, plant and equipment 180,939 188,372 Intangible assets Goodwill 2,120 1,844 Other 14,929 14,039 Total intangible assets 17,050 15,884 Investments and other assets Investment securities 30,453 32,608 Shares of subsidiaries and associates 49,398 49,685 Long-term loans receivable 8,158 9,315 Retirement benefit asset 330 224 Deferred tax assets 4,489 3,778 Other 12,695 13,966 Allowance for doubtful accounts (1,204) (1,232) Total investments and other assets 104,320 108,346 Total non-current assets 302,309 312,603 Total assets 634,878 657,016 9
Page 10
(Millions of yen) As of March 31, 2025 As of September 30, 2025 Liabilities Current liabilities Notes and accounts payable - trade 56,439 56,966 Short-term borrowings 114,104 121,840 Income taxes payable 3,639 4,867 Accrued expenses 29,121 27,416 Provisions 4,436 4,400 Other 18,437 17,403 Total current liabilities 226,179 232,895 Non-current liabilities Long-term borrowings 95,832 112,865 Provisions 249 105 Retirement benefit liability 7,694 7,272 Other 18,981 20,159 Total non-current liabilities 122,758 140,403 Total liabilities 348,938 373,299 Net assets Shareholders' equity Share capital 30,685 30,685 Capital surplus 21,833 21,844 Retained earnings 171,996 181,307 Treasury shares (708) (6,569) Total shareholders' equity 223,806 227,268 Accumulated other comprehensive income Valuation difference on available-for-sale securities 12,969 14,536 Deferred gains or losses on hedges 881 (415) Foreign currency translation adjustment 40,938 34,210 Remeasurements of defined benefit plans (1,555) (1,318) Total accumulated other comprehensive income 53,233 47,012 Non-controlling interests 8,900 9,436 Total net assets 285,939 283,716 Total liabilities and net assets 634,878 657,016 10
Page 11
(2) Semi- annual Consolidated Statements of Income and Comprehensive Income Semi-annual Consolidated Statement of Income (Millions of yen) For the six months ended September 30, 2024 For the six months ended September 30, 2025 Net sales 440,682 452,943 Cost of sales 369,945 378,532 Gross profit 70,737 74,410 Selling, general and administrative expenses 53,461 54,618 Operating profit 17,276 19,791 Non-operating income Interest income 265 298 Dividend income 408 480 Share of profit of entities accounted for using equity method 2,512 1,129 Subsidy income 78 723 Miscellaneous income 344 304 Total non-operating income 3,609 2,936 Non-operating expenses Interest expenses 1,608 1,418 Foreign exchange losses 20 0 Miscellaneous expenses 171 95 Total non-operating expenses 1,800 1,514 Ordinary profit 19,085 21,213 Extraordinary income Gain on sale of non-current assets 111 412 Gain on sale of investment securities 122 - Gain on bargain purchase 151 - Gain on liquidation of subsidiaries and associates 81 - Total extraordinary income 466 412 Extraordinary losses Loss on disposal of non-current assets 235 265 Impairment losses - 76 Loss on valuation of investment securities 95 4 Loss on disaster 236 181 Total extraordinary losses 567 527 Profit before income taxes 18,983 21,098 Income taxes - current 5,386 6,068 Income taxes - deferred 48 (435) Total income taxes 5,435 5,632 Profit 13,548 15,465 Profit attributable to non-controlling interests 972 1,169 Profit attributable to owners of parent 12,576 14,296 11
Page 12
Semi-annual Consolidated Statement of Comprehensive Income (Millions of yen) For the six months ended September 30, 2024 For the six months ended September 30, 2025 Profit 13,548 15,465 Other comprehensive income Valuation difference on available-for-sale securities (884) 1,251 Deferred gains or losses on hedges (550) (1,728) Foreign currency translation adjustment 14,579 (6,266) Remeasurements of defined benefit plans, net of tax (540) 249 Share of other comprehensive income of entities accounted for using equity method 2,668 403 Total other comprehensive income 15,272 (6,091) Comprehensive income 28,821 9,374 Comprehensive income attributable to Comprehensive income attributable to owners of parent 27,846 8,076 Comprehensive income attributable to non-controlling interests 974 1,298 12
Page 13
(3) Semi- annual Consolidated Statement of Cash Flows (Millions of yen) For the six months ended September 30, 2024 For the six months ended September 30, 2025 Cash flows from operating activities Profit before income taxes 18,983 21,098 Depreciation 12,055 12,644 Impairment losses - 76 Amortization of goodwill 330 296 Increase (decrease) in allowance for doubtful accounts (11) (68) Increase (decrease) in retirement benefit liability (591) 92 Interest and dividend income (674) (778) Interest expenses 1,608 1,418 Share of loss (profit) of entities accounted for using equity method (2,512) (1,129) Gain on sale of non-current assets (111) (412) Loss on disposal of noncurrent assets 235 265 Loss (gain) on sale and valuation of investment securities (27) 4 Loss on disaster - 181 Decrease (increase) in trade receivables 4,495 (4,824) Decrease (increase) in inventories (4,076) (7,044) Increase (decrease) in trade payables (1,251) 1,953 Increase (decrease) in accrued expenses (6,253) (1,377) Other, net (88) (1,860) Subtotal 22,111 20,536 Interest and dividends received 712 1,107 Interest paid (1,651) (1,297) Proceeds from insurance income - 415 Income taxes paid (7,766) (4,218) Net cash provided by (used in) operating activities 13,406 16,543 Cash flows from investing activities Decrease (increase) in time deposits (105) (0) Purchase of property, plant and equipment (14,098) (24,356) Proceeds from sale of property, plant and equipment 154 533 Purchase of intangible assets (533) (488) Purchase of investment securities (391) (213) Proceeds from sale of investment securities 224 0 Payments for acquisition of businesses (403) - Proceeds from purchase of shares of subsidiaries resulting in change in scope of consolidation 89 - Decrease (increase) in short-term loans receivable 254 (58) Long-term loan advances (7) (2,529) Income from compensation - 3,203 Other, net (1,491) (1,723) Net cash provided by (used in) investing activities (16,308) (25,633) 13
Page 14
(Millions of yen) For the six months ended September 30, 2024 For the six months ended September 30, 2025 Cash flows from financing activities Net increase (decrease) in short-term borrowings 10,714 26,862 Proceeds from long-term borrowings 675 18,000 Repayments of long-term borrowings (3,568) (18,030) Repayments of lease liabilities (449) (618) Dividends paid (4,355) (4,978) Dividends paid to non-controlling interests (653) (715) Decrease (increase) in treasury shares (2) (6,073) Net cash provided by (used in) financing activities 2,359 14,446 Effect of exchange rate change on cash and cash equivalents 1,043 (199) Net increase (decrease) in cash and cash equivalents 500 5,157 Cash and cash equivalents at beginning of period 19,533 18,686 Cash and cash equivalents at end of period 20,034 23,843 14
Page 15
(4) Notice concerning the consolidated financial statements (Notes on Going Concern) Not applicable. (Notes Regarding Significant Changes in the Amount of Shareholders’ Equity) At the Board of Directors meeting held on May 14, 2025, the Company resolved, pursuant to Article 156, Paragraph 1 of the Companies Act as applied by replacing the terms pursuant to Article 165, Paragraph 3 of the same Act and in accordance with the Company’s Articles of Incorporation, to acquire its own shares through a tender offer. As a result, on July 3, 2025, the Company acquired 7,864,875 shares of treasury stock. Mainly due to this acquisition, treasury stock increased by 5,861 million yen, resulting in a balance of 6,569 million yen at the end of the interim of the current consolidated fiscal period. (Additional Information) (Finalization of Provisional Accounting Treatment for Equity-Method Investments) Provisional accounting treatment was applied to an equity-method affiliate acquired through a business combination in the interim of the previous consolidated fiscal year It was finalized in the third quarter of the previous consolidated fiscal year. Following this finalization, the equity-method affiliate recorded a gain on negative goodwill. Accordingly, the comparative information presented in the quarterly consolidated financial statements for the interim of the previous fiscal year has been revised. As a result, in the consolidated statement of income for the interim of the previous fiscal year, the share of profit of entities accounted for using the equity method increased by 2,108 million yen, and the income taxes deferred increased by 31 million yen. In addition to these changes, the share of other comprehensive income of entities accounted for using the equity method increased by 143 million yen in the consolidated statement of comprehensive income. 15
Page 16
(Segment Information, etc.) 1. 2n d Quarter of the previous Fiscal Year (April 1, 2024, September 30, 2024) 1. I nformation on net sales and profit (loss) by reportable segment (Unit: Million yen) Marine Products Food Products Fine Chemicals General Distribution Total Sales (1) Sales to third parties 175,590 239,858 7,298 8,253 431,002 9,680 440,682 - 440,682 9,081 485 256 6,674 16,499 848 17,347 (17,347) - Total 184,672 240,344 7,555 14,928 447,501 10,528 458,030 (17,347) 440,682 Segment income 3,512 16,323 105 1,324 21,266 625 21,892 (4,616) 17,276 Other (Note1) Total Adjustement (Note 2) Consolidated (Note.3) (2) Inter-segment sales and transfers Information by business segments ( Note) 1. The “Other” segment includes the building/repair ing of ships, engineering, operation, and other businesses not included in the reportable segments. 2. The (4,616) million yen segment profit adjustment comprises 61 million yen in inter -segment eliminations and ( 4,677) million yen in corporate expenses not allocated to the segments. Corporate expenses are mainly comprised of selling, general, and administrative expenses not allocated to the segments. 3. Segment income is adjusted to reflect operating profit as the interim income statement records. 2. Information regarding impairment loss on non-current assets and goodwill by reportable segment (Significant impairment loss on non-current assets) Not applicable. (Significant changes in the amount of goodwill) Not applicable. (Significant gain on negative goodwill) Not applicable. 16
Page 17
2. 2nd Quarter of the current Fiscal Year (April 1, 2025 -September 30, 2025) 1. Information on net sales and profit (loss) by reportable segment (Unit: Million yen) Marine Products Food Products Fine Chemicals General Distribution Total Sales (1) S ales to third parties 178,806 251,790 7,109 8,356 446,063 6,879 452,943 - 452,943 8,117 1,656 207 7,143 17,125 371 17,496 (17,496) - Total 186,924 253,447 7,316 15,500 463,188 7,251 470,439 (17,496) 452,943 Segment income 6,078 16,830 174 1,238 24,322 346 24,668 (4,877) 19,791 Other (Note1) Total Adjustement (Note 2) Consolidated (Note.3) (2) Inter-segment sales and transfers Information by business segments ( Note) 1. The “Other” segment includes the building/repairing of ships, engineering, operations, and other businesses not included in the reportable segments. 2. The (4,877) million yen segment income adjustment comprises 58 million yen in inter-segment transactions and ( 4,935) million yen in corporate expenses not allocated to the segments. Corporate expenses are mainly comprised of selling, general, and administrative costs not allocated to the segments. 3. Segment income is adjusted to reflect operating profit in the interim income statement. 2. Information regarding impairment loss on non-current assets and goodwill by reportable segment (Significant impairment loss on non-current assets) Disclosure is omitted due to immateriality. (Significant changes in the amount of goodwill) Not applicable. (Significant gain on negative goodwill) Not applicable. 17